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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idZika virus infection in Colombia was ﬁrst notiﬁed in August
2015, and the ﬁrst cases of native transmission occurred in October
of that year.1–3 The infection has been associated with several
complications including certain neurological disorders, such as an
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).increased incidence of Guillain–Barre´ syndrome (estimated odds
ratio >34), microcephaly, and polyneuropathy. The health care
systems of affected countries and the World Health Organization
have increased efforts towards research, prevention, and control
because of the multiple negative implications of this infection in
the population.4,5 Colombia has experienced the second highest
number of cases of Zika virus infection in South America.2
Following the publication of a review article reporting the
increased risk of neurological disorders caused by Zika virus
infection,5 all records of these diagnoses reported as the primary
diagnosis in a population database of about 6.5 million people,
corresponding to 14.1% of the population of Colombia, were
investigated. This resulted in a descriptive study of all patients of
any age afﬁliated with the Colombian health care system who
were treated at a medical consultation and received a prescription
for neurological or psychiatric medication between January
2015 and March 2016. Data were obtained from the database
of the largest drug dispenser in the country, Audifarma S.A., and
validated.and neurological disorders in a population database of Colombia, 2014-2016.
ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
J.E. Machado-Alba et al. / International Journal of Infectious Diseases 51 (2016) 133–134134A total of 81 neurological disorders included in the Interna-
tional Statistical Classiﬁcation of Diseases and Related Health
Problems 10th Revision (ICD-10) were identiﬁed during the
observation period (diagnoses of myelopathy, neuropathy, paraly-
sis, and demyelinating disorders were included). The number of
new monthly cases of Guillain–Barre´ syndrome remained stable
during the ﬁrst 7 months of 2015, but from August 2015, when Zika
virus infection ﬁrst appeared in Colombia, the number of reported
cases started to increase, reaching a four-fold increase in March
2016, the time of the greatest number of reported cases in the
country (Figure 1). During the same period of time, the number of
new diagnoses of other neurological disorders showed no increase
(Figure 1). From the beginning of the epidemic phase (week 40,
2015) to epidemiological week 15 of 2016, there were 3292 con-
ﬁrmed cases and 68 660 suspected cases of infection in Colombia.3
These results suggest the possibility that Zika virus infection is
associated with Guillain–Barre´ syndrome (besides microcephaly),
but not with other neurological disorders. Prompt conﬁrmation of
the infection and increased measures aimed at searching for and
identifying Guillain–Barre´ syndrome should be promoted in order to
start treatment early and avoid the appearance of complications.5–7Funding: This research did not receive funding.
Conﬂict of interest: All authors declare that they have no conﬂict
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